Cargando…

ImmGen Report: Molecular definition of Natural Killer cell identity and activation

Using whole-genome microarray datasets of the Immunological Genome Project, we demonstrate a closer transcriptional relationship between NK and T cells than any other leukocytes, distinguished by their expression of similar signaling functions. While resting NK cells were known to share expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezman, Natalie A., Kim, Charles C., Sun, Joseph C., Min-Oo, Gundula, Hendricks, Deborah W., Kamimura, Yosuke, Best, J. Adam, Goldrath, Ananda W., Lanier, Lewis L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572860/ https://www.ncbi.nlm.nih.gov/pubmed/22902830 http://dx.doi.org/10.1038/ni.2395

Ejemplares similares

ImmGen report: sexual dimorphism in the immune system transcriptome
por: Gal-Oz, Shani Talia, et al.
Publicado: (2019)

Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes
por: Gainullina, Anastasiia, et al.
Publicado: (2023)

Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection
por: Min-Oo, Gundula, et al.
Publicado: (2014)

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
por: Sun, Joseph C., et al.
Publicado: (2011)

Proinflammatory cytokine signaling required for the generation of natural killer cell memory
por: Sun, Joseph C., et al.
Publicado: (2012)

Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)

Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection
por: Min-Oo, Gundula, et al.
Publicado: (2014)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)

Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
por: Ilyinskii, Petr O., et al.
Publicado: (2021)

License to kill: Retinoic acid programs T cells for tissue residency
por: Heeg, Maximilian, et al.
Publicado: (2023)

Adaptive Federated IMM Filter for AUV Integrated Navigation Systems
por: Lyu, Weiwei, et al.
Publicado: (2020)

Breakdown of the Isobaric Multiplet Mass Equation (IMME) at A=33, T=3/2
por: Herfurth, F, et al.
Publicado: (2000)

ImmTACs: Novel bi-specific agents for targeted cancer therapy
por: Oates, Joanne, et al.
Publicado: (2013)

An IMM-Aided ZUPT Methodology for an INS/DVL Integrated Navigation System
por: Yao, Yiqing, et al.
Publicado: (2017)

Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
por: Kishimoto, Takashi Kei
Publicado: (2020)

Turning on Natural Killer Cells
por: Lanier, Lewis L.
Publicado: (2000)

ImmTree: Database of evolutionary relationships of genes and proteins in the human immune system
por: Ortutay, Csaba, et al.
Publicado: (2007)

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
por: Bilyard, Hilary, et al.
Publicado: (2014)

LinkedImm: a linked data graph database for integrating immunological data
por: Bukhari, Syed Ahmad Chan, et al.
Publicado: (2021)

ImmReg: the regulon atlas of immune-related pathways across cancer types
por: Jiang, Tiantongfei, et al.
Publicado: (2021)

The TCR’s sensitivity to self-peptide–MHC dictates the ability of naïve CD8(+) T cells to respond to foreign antigens
por: Fulton, Ross B., et al.
Publicado: (2014)

E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment
por: Ikawa, Tomokatsu, et al.
Publicado: (2006)

Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation
por: Goldrath, Ananda W., et al.
Publicado: (2000)

Organización administrativa y contable de un hospital de zona del IMMS.
por: Palacios López, Jose Luis
Publicado: (1987)

Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
por: Woelke, Anna Lena, et al.
Publicado: (2011)

iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model
por: Khodaee, Saeideh, et al.
Publicado: (2020)

Adaptive Immune Features of Natural Killer Cells
por: Sun, Joseph C., et al.
Publicado: (2009)

Activation of TnSmu1, an integrative and conjugative element, by an ImmR-like transcriptional regulator in Streptococcus mutans
por: King, Shawn, et al.
Publicado: (2022)

Improving the iMM904 S. cerevisiae metabolic model using essentiality and synthetic lethality data
por: Zomorrodi, Ali R, et al.
Publicado: (2010)

ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
por: Donnellan, Zoe, et al.
Publicado: (2015)

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
por: Boudousquie, Caroline, et al.
Publicado: (2017)

ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
por: Bhattacharya, Sanchita, et al.
Publicado: (2018)

ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues
por: Jiang, Tiantongfei, et al.
Publicado: (2022)

Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
por: Ilyinskii, Petr O., et al.
Publicado: (2021)

Differential contribution of transcriptomic regulatory layers in the definition of neuronal identity
por: Ha, Kevin C. H., et al.
Publicado: (2021)

Natural killer cells as an initial defense against pathogens
por: Lodoen, Melissa B, et al.
Publicado: (2006)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4o3je1qpq308tsk8d9imtcrkcg